Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905, USA.
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):971-7. doi: 10.1016/j.ijrobp.2012.08.025.
This prospective cohort study was designed to determine whether the amount of radiation delivered to the nonpathological lymph nodes (LNs) that drain the arm can be significantly reduced by integrating single-photon emission computed tomography (SPECT)/computed tomography (CT) scans into radiation treatment planning.
SPECT-CT scans were acquired for the 28 patients with stage I or II breast cancer and fused with the routinely obtained radiation oncology planning CT scans. Arm-draining LNs were contoured with 0.5-cm margins automatically using a threshold of 50% maximum intensity. Two treatment plans were generated: 1 per routine clinical practice (standard; STD) and the second (modified; MOD) with treatment fields modified to minimize dose to the arm-draining LNs visible on SPECT/CT images without interfering with the dosage delivered to target tissues. Participants were treated per the MOD plans. Arm volumes were measured prior to radiation and thereafter at least three subsequent 6-month intervals.
Sixty-eight level I-III arm-draining LNs were identified, 57% of which were inside the STD plan fields but could be blocked in the MOD plan fields. Sixty-five percent of arm-draining LNs in the STD versus 16% in the MOD plans received a mean of ≥10 Gy, and 26% in the STD versus 4% in the MOD plans received a mean of ≥40 Gy. Mean LN radiation exposure was 23.6 Gy (standard deviation 18.2) with the STD and 7.7 Gy (standard deviation 11.3) with the MOD plans (P<.001). No participant developed lymphedema.
The integration of SPECT/CT scans into breast cancer radiation treatment planning reduces unnecessary arm-draining LN radiation exposure and may lessen the risk of lymphedema.
本前瞻性队列研究旨在确定通过将单光子发射计算机断层扫描(SPECT)/计算机断层扫描(CT)扫描整合到放射治疗计划中,是否可以显著减少引流手臂的非病理性淋巴结(LNs)所接受的辐射量。
对 28 名 I 期或 II 期乳腺癌患者进行 SPECT-CT 扫描,并与常规获得的放射肿瘤学计划 CT 扫描融合。使用 50%最大强度的阈值自动对引流臂的 LNs 进行 0.5cm 边界勾画。生成两种治疗计划:一种是常规临床实践(标准;STD),另一种是(改良;MOD),治疗野修改为最小化 SPECT/CT 图像上可见的引流臂 LNs 的剂量,而不干扰对目标组织的剂量。参与者根据 MOD 计划进行治疗。在放射治疗前和此后至少三个后续的 6 个月间隔测量手臂体积。
共识别出 68 个 I-III 级引流臂 LNs,其中 57%位于 STD 计划野内,但可在 MOD 计划野中被遮挡。STD 计划中有 65%的引流臂 LNs 接受了≥10Gy 的平均剂量,而 MOD 计划中有 16%的引流臂 LNs 接受了≥40Gy 的平均剂量。STD 计划中 LN 辐射暴露的平均值为 23.6Gy(标准差 18.2),MOD 计划中为 7.7Gy(标准差 11.3)(P<.001)。没有参与者发生淋巴水肿。
将 SPECT/CT 扫描整合到乳腺癌放射治疗计划中,可以减少不必要的引流臂 LNs 辐射暴露,并可能降低淋巴水肿的风险。